PHARMACEUTICAL COMPOSITION FOR PREVENTION OF PROGRESS OF INTESTINAL CONSTRICTION ASSOCIATED WITH CROHN'S DISEASE

摘要

Disclosed is an oral pharmaceutical composition for preventing the progress of the intestinal constriction associated with Crohn's disease. Specifically disclosed is a pharmaceutical composition for preventing the progress of the intestinal constriction associated with Crohn's disease, which comprises N-(3,4-dimethoxycinnamoyl)anthranilic acid (generic name: tranilast) or a pharmacologically acceptable salt thereof as an active ingredient. The pharmaceutical composition is useful as an agent for preventing the progress of the intestinal constriction associated with Crohn's disease for use in a medical treatment.